The Antipsychotic Effects of Omega-3 Fatty Acids in Rats
Background In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral r...
Saved in:
Published in: | The American journal of the medical sciences Vol. 350; no. 3; pp. 212 - 217 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
01-09-2015
Copyright by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. Methods Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA: 120 mg/kg + EPA: 180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA: 60 mg/kg + EPA: 90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. Results This study shows that omega-3 fatty acids, “similar to antipsychotics,” reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. Conclusions The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids. |
---|---|
AbstractList | BACKGROUND:In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats.
METHODS:Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA120 mg/kg + EPA180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA60 mg/kg + EPA90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior.
RESULTS:This study shows that omega-3 fatty acids, “similar to antipsychotics,” reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats.
CONCLUSIONS:The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids. In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment-or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors-they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA: 120 mg/kg + EPA: 180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA: 60 mg/kg + EPA: 90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. This study shows that omega-3 fatty acids, "similar to antipsychotics," reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids. BACKGROUNDIn humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment-or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors-they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats.METHODSTwenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA: 120 mg/kg + EPA: 180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA: 60 mg/kg + EPA: 90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior.RESULTSThis study shows that omega-3 fatty acids, "similar to antipsychotics," reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats.CONCLUSIONSThe application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids. In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300mg/kg; DHA: 120mg/kg + EPA: 180mg/kg intraperitoneally [IP]), DHA + EPA (150mg/kg; DHA: 60mg/kg + EPA: 90mg/kg IP), chlorpromazine (1mg/kg, IP) and isotonic saline (1mL/kg, IP). One hour later, apomorphine (2mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. This study shows that omega-3 fatty acids, “similar to antipsychotics,” reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids. Background In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new environment—or as a result of an apomorphine application that creates an agonistic effect on D1 and D2 receptors—they display behavioral reactions like rearing and stereotypy. This study aims to reveal the possible antipsychotic and oxidative effects of omega-3 fatty acids by comparing with chlorpromazine, a conventional antipsychotic drug, through evaluating the novelty-induced rearing and apomorphine-induced stereotypic behaviors, as well as malondialdehyde and glutathione levels in rats. Methods Twenty-eight, adult, male, Wistar rats were used in the study. Briefly, 4 groups of rats (n = 7) were administered docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) (300 mg/kg; DHA: 120 mg/kg + EPA: 180 mg/kg intraperitoneally [IP]), DHA + EPA (150 mg/kg; DHA: 60 mg/kg + EPA: 90 mg/kg IP), chlorpromazine (1 mg/kg, IP) and isotonic saline (1 mL/kg, IP). One hour later, apomorphine (2 mg/kg, subcutaneously) was administered to each rat. After the apomorphine administration, rats were observed for stereotypic behavior. Results This study shows that omega-3 fatty acids, “similar to antipsychotics,” reversed the psychotic like effects, increase of oxidants and decrease of antioxidants that are composed experimentally in rats. Conclusions The application of omega-3 fatty acids has antipsychotic effects and causes an oxidative imbalance. This study adds new evidence to the current literature regarding the possible antipsychotic effects of omega-3 fatty acids. |
Author | Erbas, Oytun Dokuyucu, Recep Inanir, Sema Kokacya, Mehmet Hanifi Copoglu, Umit Sertan |
AuthorAffiliation | Departments of Psychiatry (MHK, USC) and Physiology (RD), Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey; and Departments of Psychiatry (SI) and Physiology (OE), Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey |
AuthorAffiliation_xml | – name: Departments of Psychiatry (MHK, USC) and Physiology (RD), Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey; and Departments of Psychiatry (SI) and Physiology (OE), Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey |
Author_xml | – sequence: 1 fullname: Kokacya, Mehmet Hanifi, MD – sequence: 2 fullname: Copoglu, Umit Sertan, MD – sequence: 3 fullname: Dokuyucu, Recep, MD – sequence: 4 fullname: Inanir, Sema, MD – sequence: 5 fullname: Erbas, Oytun, MD |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26200950$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkU1LHEEQhpugxNXkHwSZo5fR_pjpj4uwiCaKIhhzbnp6qrOts9Nrd09k_316WRPEi1iXguJ93yqe2kc7YxgBoW8EHxOsxMnN_OoYv66WkU9oRloma6oU3kGzMqS14lTtof2UHjAmVBL2Ge1RTjFWLZ4heb-Aaj5mv0pruwjZ2-rcObA5VcFVt0v4bWpWXZic19Xc-j5VfqzuTE5f0K4zQ4KvL_0A_bo4vz_7UV_ffr88m1_XtuGc1FKBpKoc4oTjHVXMkqYTzIm2F70gjmPDe0GdaKyhzAhMJSOdkh3hIKCz7AAdbXNXMTxNkLJe-mRhGMwIYUqaCCylkq1QRdpspTaGlCI4vYp-aeJaE6w3zHRhpt8yK7bDlw1Tt4T-v-kfpCKQW8FzGDLE9DhMzxD1AsyQF-9ln26tUBD98cWVrIfRQu9jgaz74D8aYAc_emuGR1hDeghTHAt-TXSiGuufm5dvPk7ahlCuJPsLUJ-eyw |
CitedBy_id | crossref_primary_10_1007_s00238_020_01757_2 crossref_primary_10_1155_2017_6285218 crossref_primary_10_1007_s11695_023_06560_z crossref_primary_10_1002_ddr_22225 crossref_primary_10_1177_0271678X241261949 |
Cites_doi | 10.1016/S0896-6273(04)00048-0 10.1176/appi.ajp.158.12.2071 10.1080/09540260600581993 10.1016/j.schres.2012.08.014 10.1038/sj.bjp.0702350 10.1016/j.neulet.2010.05.088 10.1016/j.jnutbio.2008.12.015 10.1016/j.lfs.2014.11.025 10.1016/j.biopsych.2013.06.007 10.1016/j.neuroscience.2013.11.049 10.1001/archgenpsychiatry.2009.192 10.1093/brain/122.4.593 10.1016/S0022-3956(01)00048-6 10.1016/j.pnpbp.2013.06.007 10.1016/0014-2999(78)90236-4 10.1001/archgenpsychiatry.2008.514 10.4196/kjpp.2009.13.2.71 10.2174/157015911795596595 10.1080/10715760701324067 10.1016/j.neubiorev.2010.10.008 10.4088/JCP.v68n1206 10.1016/j.pnpbp.2008.07.001 10.1176/ajp.148.11.1474 10.1097/JCP.0b013e318248b7bb 10.1385/MN:32:1:089 10.1016/j.schres.2013.02.001 10.1523/JNEUROSCI.03-08-01607.1983 10.1016/S0920-9964(01)00334-6 10.1146/annurev.neuro.25.112701.142754 10.1126/science.1355616 10.3389/fgene.2013.00208 10.1016/j.jep.2012.06.026 10.1016/S0278-5846(02)00220-8 10.1016/j.plefa.2013.11.002 10.1093/ajcn/64.3.297 10.1016/j.pnpbp.2006.09.012 10.1093/sw/53.1.77 10.1038/sj.mp.4000956 10.1016/0024-3205(84)90519-8 10.1016/0003-9861(59)90090-6 10.1016/j.cbi.2013.10.008 10.1023/A:1006875010120 10.1016/0003-2697(76)90527-3 10.1007/BF02859265 10.1016/S0024-3205(00)00638-X 10.1016/j.jep.2004.10.003 10.1007/s00213-005-0117-1 10.1016/j.plefa.2003.08.015 10.1093/oxfordjournals.schbul.a007038 10.1038/mp.2011.20 10.1111/j.1399-5618.2009.00717.x 10.1016/S0920-9964(00)00083-9 10.1016/S0920-9964(97)00151-5 10.1016/j.schres.2012.08.002 10.1155/2013/686304 10.1016/0920-9964(94)90043-4 |
ContentType | Journal Article |
Copyright | Southern Society for Clinical Investigation 2015 Southern Society for Clinical Investigation Copyright © 2015 by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited. |
Copyright_xml | – notice: Southern Society for Clinical Investigation – notice: 2015 Southern Society for Clinical Investigation – notice: Copyright © 2015 by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1097/MAJ.0000000000000531 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-2990 |
EndPage | 217 |
ExternalDocumentID | 10_1097_MAJ_0000000000000531 26200950 10.1097/MAJ.0000000000000531 S0002962915412698 1_s2_0_S0002962915412698 |
Genre | Journal Article |
GroupedDBID | --- .-D .1- .55 .FO .GJ .Z2 0R~ 123 1P~ 23M 354 41~ 457 4Q1 4Q2 4Q3 53G 5RE 5VS 6J9 6TS 71W 7X3 AADOR AAKAS AALRI AAXUO ABBUW ABJNI ABPPZ ABZAD ACDDN ACGFO ACGFS ACWDW ACWRI ADBIZ ADFPA ADMHG ADOJD ADZCM AE3 AENEX AEVXI AFCTW AFETI AFFNX AFJKZ AFRHN AFTJW AFTRI AFUWQ AGHFR AGINI AHPAA AHRYX AHVBC AI. AITUG AIZYK AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ AWKKM BS7 C45 CS3 D1Z E.X EBS EJD EX3 F2K F2L F5P FDB FL- H0~ HYQOX HZ~ IN~ IS. JF9 JG8 JK3 JK8 K8S KD2 KMI L7B LPU M1B MVM N4W N9A N~M O9- OAG OAH OBH OCUKA ODA OD~ OHH OHT OL1 OLB OLG OLV OLZ ORVUJ OVD OWU OWV OWW OWX OWY OWZ P-K P2P R58 ROL S4R S4S T8P TEORI UQL V2I VH1 VVN W3M WH7 WOQ WOW X3V X3W X7M XXN XYM YOC YXB Z5R ZGI ZXP ~02 AAIAV AHPSJ AQNKT - 02 08R 0R 1P 41 55 AAPBV ABFLS ADKZR AJYGW AQIPR FO GJ H0 HZ IN M41 OD RIG RLZ RSW Z2 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4661-89e829000f7f6b293c14b73f75d7d71f60a6d72f74ca23a702831b98b16e7ebc3 |
ISSN | 0002-9629 |
IngestDate | Fri Oct 25 22:42:34 EDT 2024 Thu Nov 21 21:50:49 EST 2024 Tue Oct 15 23:49:42 EDT 2024 Thu Aug 13 19:54:42 EDT 2020 Fri Feb 23 02:25:18 EST 2024 Tue Oct 15 14:38:10 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Antipsychotic effect Oxidative stress Omega-3 fatty acids |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4661-89e829000f7f6b293c14b73f75d7d71f60a6d72f74ca23a702831b98b16e7ebc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 26200950 |
PQID | 1708898579 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1708898579 crossref_primary_10_1097_MAJ_0000000000000531 pubmed_primary_26200950 wolterskluwer_health_10_1097_MAJ_0000000000000531 elsevier_sciencedirect_doi_10_1097_MAJ_0000000000000531 elsevier_clinicalkeyesjournals_1_s2_0_S0002962915412698 |
ProviderPackageCode | C45 .Z2 ADFPA AWKKM OLG ODA ABZAD ABBUW JK3 OBH JK8 H0~ ORVUJ OLV JG8 X3V OLZ X3W F2K ACDDN ACWRI F2L AHVBC FL- KMI K8S V2I E.X OWW OCUKA OWY S4R S4S 4Q1 OAG 4Q2 OL1 4Q3 OAH IN~ KD2 ACWDW JF9 OVD 71W |
PublicationCentury | 2000 |
PublicationDate | 2015-September |
PublicationDateYYYYMMDD | 2015-09-01 |
PublicationDate_xml | – month: 09 year: 2015 text: 2015-September |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The American journal of the medical sciences |
PublicationTitleAlternate | Am J Med Sci |
PublicationYear | 2015 |
Publisher | Elsevier Inc Copyright by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited |
Publisher_xml | – name: Elsevier Inc – name: Copyright by the Southern Society for Clinical Investigation. Unauthorized reproduction of this article is prohibited |
References | Lewis, Levitt (bb0015) 2002; 25 Corcoran, Walker, Huot (bb0020) 2003; 29 Bradford (bb0170) 1976; 72 Creese, Manian, Prosser (bb0220) 1978; 47 Walting (bb0190) 1998 Howes, Montgomery, Asselin (bb0255) 2009; 66 Fusar-Poli, Berger (bb0080) 2012; 32 Erbas, Akseki, Elikucuk (bb0235) 2013; 2013 Harrison (bb0025) 1999; 122 Gama, Canever, Panizzutti (bb0115) 2012; 141 Kunz, Gama, Andreazza (bb0070) 2008; 32 Pearce (bb0030) 2001; 6 Reavill, Kettle, Holland (bb0155) 1999; 126 Peet, Horrobin (bb0085) 2002; 36 Zugno, Chipindo, Canever (bb0270) 2015; 121 Peet, Brind, Ramchand (bb0275) 2001; 49 Horrobin, Glen, Vaddadi (bb0100) 1994; 13 Ballesteros, Jiang, Summerfelt (bb0090) 2013; 146 Amminger, Schäfer, Papageorgiou (bb0200) 2010; 67 Dokuyucu, Kokacya, Inanir (bb0230) 2014; 7 Stadtman (bb0045) 1992; 257 Tappia, Ladha, Clark (bb0205) 1997; 166 Shaaban, Shaker, Zalata (bb0140) 2014; 207 Horrobin (bb0055) 1998; 30 Barnes (bb0180) 2008; 53 Padurariu, Ciobica, Dobrin (bb0060) 2010; 479 Wang, Shao, Sun (bb0065) 2009; 11 Yao, Gainetdinov, Arbuckle (bb0215) 2004; 41 Mahadik, Pillai, Joshi (bb0130) 2006; 18 Sotoing Taïwe, Ngo Bum, Talla (bb0185) 2012; 143 Bitanihirwe, Woo (bb0035) 2011; 35 Howes, Bose, Turkheimer (bb0260) 2011; 16 Boskovic, Vovk, Plesničar (bb0040) 2011; 9 English, Harauma, Föcking (bb0300) 2013; 4 Chiodo, Bunney (bb0225) 1983; 3 Akyol, Herken, Uz (bb0050) 2002; 26 Amos, Abbah, Chindo (bb0160) 2005; 97 Grignon, Chianetta (bb0305) 2007; 31 Davis, Kahn, Ko (bb0010) 1991; 148 Giordano, Visioli (bb0285) 2014; 90 Berger, Proffitt, McConchie (bb0075) 2007; 68 Dong, Kim, Heo (bb0150) 2009; 13 Bazan (bb0240) 2005; 32 Palozza, Sgarlata, Luberto (bb0290) 1996; 64 Fenton, Dickerson, Boronow (bb0280) 2001; 158 Demougeot, Marie, Beley (bb0165) 2000; 67 Bondi, Taha, Tock (bb0265) 2014; 75 Trevizol, Roversi, Dias (bb0125) 2013; 45 Kawashima, Harada, Tami (bb0135) 2010; 21 Yao, Sistilli, van Kammen (bb0250) 2003; 69 Ajayi, Ukponmwan (bb0145) 1994; 23 Ellman (bb0175) 1959; 82 Khan, Evans, Gunna (bb0245) 2002; 58 Dakhale, Khanzode, Khanzode (bb0210) 2005; 182 Avramovic, Dragutinovic, Krstic (bb0110) 2012; 16 Leonardi, Attorri, Benedetto (bb0295) 2007; 41 van der Kemp, Klomp, Kahn (bb0105) 2012; 141 Stoof, Kebabian (bb0195) 1984; 35 Singh (bb0095) 2005; 72 Zugno, Chipindo, Volpato (bb0120) 2013; 259 Wang (10.1097/MAJ.0000000000000531_bb0065) 2009; 11 Corcoran (10.1097/MAJ.0000000000000531_bb0020) 2003; 29 Amminger (10.1097/MAJ.0000000000000531_bb0200) 2010; 67 Grignon (10.1097/MAJ.0000000000000531_bb0305) 2007; 31 Yao (10.1097/MAJ.0000000000000531_bb0250) 2003; 69 Barnes (10.1097/MAJ.0000000000000531_bb0180) 2008; 53 Bondi (10.1097/MAJ.0000000000000531_bb0265) 2014; 75 Horrobin (10.1097/MAJ.0000000000000531_bb0055) 1998; 30 Palozza (10.1097/MAJ.0000000000000531_bb0290) 1996; 64 Erbas (10.1097/MAJ.0000000000000531_bb0235) 2013; 2013 Avramovic (10.1097/MAJ.0000000000000531_bb0110) 2012; 16 Padurariu (10.1097/MAJ.0000000000000531_bb0060) 2010; 479 Kawashima (10.1097/MAJ.0000000000000531_bb0135) 2010; 21 Stadtman (10.1097/MAJ.0000000000000531_bb0045) 1992; 257 Bazan (10.1097/MAJ.0000000000000531_bb0240) 2005; 32 Stoof (10.1097/MAJ.0000000000000531_bb0195) 1984; 35 Boskovic (10.1097/MAJ.0000000000000531_bb0040) 2011; 9 Howes (10.1097/MAJ.0000000000000531_bb0255) 2009; 66 Ajayi (10.1097/MAJ.0000000000000531_bb0145) 1994; 23 Zugno (10.1097/MAJ.0000000000000531_bb0120) 2013; 259 Gama (10.1097/MAJ.0000000000000531_bb0115) 2012; 141 Tappia (10.1097/MAJ.0000000000000531_bb0205) 1997; 166 Reavill (10.1097/MAJ.0000000000000531_bb0155) 1999; 126 Sotoing Taïwe (10.1097/MAJ.0000000000000531_bb0185) 2012; 143 Fusar-Poli (10.1097/MAJ.0000000000000531_bb0080) 2012; 32 Walting (10.1097/MAJ.0000000000000531_bb0190) 1998 Peet (10.1097/MAJ.0000000000000531_bb0085) 2002; 36 Howes (10.1097/MAJ.0000000000000531_bb0260) 2011; 16 Shaaban (10.1097/MAJ.0000000000000531_bb0140) 2014; 207 Peet (10.1097/MAJ.0000000000000531_bb0275) 2001; 49 Chiodo (10.1097/MAJ.0000000000000531_bb0225) 1983; 3 van der Kemp (10.1097/MAJ.0000000000000531_bb0105) 2012; 141 Bradford (10.1097/MAJ.0000000000000531_bb0170) 1976; 72 Giordano (10.1097/MAJ.0000000000000531_bb0285) 2014; 90 English (10.1097/MAJ.0000000000000531_bb0300) 2013; 4 Bitanihirwe (10.1097/MAJ.0000000000000531_bb0035) 2011; 35 Dokuyucu (10.1097/MAJ.0000000000000531_bb0230) 2014; 7 Zugno (10.1097/MAJ.0000000000000531_bb0270) 2015; 121 Creese (10.1097/MAJ.0000000000000531_bb0220) 1978; 47 Horrobin (10.1097/MAJ.0000000000000531_bb0100) 1994; 13 Leonardi (10.1097/MAJ.0000000000000531_bb0295) 2007; 41 Kunz (10.1097/MAJ.0000000000000531_bb0070) 2008; 32 Fenton (10.1097/MAJ.0000000000000531_bb0280) 2001; 158 Yao (10.1097/MAJ.0000000000000531_bb0215) 2004; 41 Amos (10.1097/MAJ.0000000000000531_bb0160) 2005; 97 Davis (10.1097/MAJ.0000000000000531_bb0010) 1991; 148 Akyol (10.1097/MAJ.0000000000000531_bb0050) 2002; 26 Demougeot (10.1097/MAJ.0000000000000531_bb0165) 2000; 67 Harrison (10.1097/MAJ.0000000000000531_bb0025) 1999; 122 Trevizol (10.1097/MAJ.0000000000000531_bb0125) 2013; 45 Singh (10.1097/MAJ.0000000000000531_bb0095) 2005; 72 Ellman (10.1097/MAJ.0000000000000531_bb0175) 1959; 82 Mahadik (10.1097/MAJ.0000000000000531_bb0130) 2006; 18 Ballesteros (10.1097/MAJ.0000000000000531_bb0090) 2013; 146 Pearce (10.1097/MAJ.0000000000000531_bb0030) 2001; 6 Khan (10.1097/MAJ.0000000000000531_bb0245) 2002; 58 Lewis (10.1097/MAJ.0000000000000531_bb0015) 2002; 25 Dakhale (10.1097/MAJ.0000000000000531_bb0210) 2005; 182 Berger (10.1097/MAJ.0000000000000531_bb0075) 2007; 68 Dong (10.1097/MAJ.0000000000000531_bb0150) 2009; 13 |
References_xml | – volume: 122 start-page: 593 year: 1999 end-page: 624 ident: bb0025 article-title: The neuropathology of schizophrenia. A critical review of the data and their interpretation publication-title: Brain contributor: fullname: Harrison – volume: 49 start-page: 243 year: 2001 end-page: 251 ident: bb0275 article-title: Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia publication-title: Schizophr Res contributor: fullname: Ramchand – volume: 32 start-page: 1677 year: 2008 end-page: 1681 ident: bb0070 article-title: Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizo-phrenia publication-title: Prog Neuropsychopharmacol Biol Psychiatry contributor: fullname: Andreazza – volume: 158 start-page: 2071 year: 2001 end-page: 2074 ident: bb0280 article-title: A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cog-nitive impairment in schizophrenia publication-title: Am J Psychiatry contributor: fullname: Boronow – volume: 68 start-page: 1867 year: 2007 end-page: 1875 ident: bb0075 article-title: Ethyl-eicosapentaenoic acid in first-episode psycho-sis: a randomized, placebo-controlled trial publication-title: J Clin Psychiatry contributor: fullname: McConchie – volume: 26 start-page: 995 year: 2002 end-page: 1005 ident: bb0050 article-title: The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance publication-title: Prog Neuropsychopharmacol Biol Psychiatry contributor: fullname: Uz – volume: 35 start-page: 2281 year: 1984 end-page: 2296 ident: bb0195 article-title: Two dopamine receptors: biochemistry, physiology and pharmacology publication-title: Life Sci contributor: fullname: Kebabian – volume: 259 start-page: 223 year: 2013 end-page: 231 ident: bb0120 article-title: Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia publication-title: Neuroscience contributor: fullname: Volpato – volume: 166 start-page: 135 year: 1997 end-page: 143 ident: bb0205 article-title: The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cyto-kine production in rats fed a variety of fat diets publication-title: Mol Cell Biochem contributor: fullname: Clark – volume: 207 start-page: 81 year: 2014 end-page: 91 ident: bb0140 article-title: Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3 publication-title: Chem Biol Interact contributor: fullname: Zalata – volume: 29 start-page: 671 year: 2003 end-page: 692 ident: bb0020 article-title: The stress cascade and schizophrenia: etiology and onset publication-title: Schizophr Bull contributor: fullname: Huot – volume: 9 start-page: 301 year: 2011 ident: bb0040 article-title: Oxidative stress in schizophrenia publication-title: Curr Neuropharmacol contributor: fullname: Plesničar – volume: 18 start-page: 119 year: 2006 end-page: 131 ident: bb0130 article-title: Prevention of oxidative stress-mediated neuropa-thology and improved clinical outcome by adjunctive use of a combina-tion of antioxidants and omega-3 fatty acids in schizophrenia publication-title: Int Rev Psychiatry contributor: fullname: Joshi – volume: 90 start-page: 1 year: 2014 end-page: 4 ident: bb0285 article-title: Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions publication-title: Prostaglandins Leukot Essent Fatty Acids contributor: fullname: Visioli – volume: 58 start-page: 1 year: 2002 end-page: 10 ident: bb0245 article-title: Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsy-chotics publication-title: Schizophr Res contributor: fullname: Gunna – volume: 32 start-page: 89 year: 2005 end-page: 103 ident: bb0240 article-title: Lipid signaling in neural plasticity, brain repair, and neuroprotection publication-title: Mol Neurobiol contributor: fullname: Bazan – volume: 121 start-page: 65 year: 2015 end-page: 69 ident: bb0270 article-title: Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizo-phrenia publication-title: Life Sci contributor: fullname: Canever – volume: 182 start-page: 494 year: 2005 end-page: 498 ident: bb0210 article-title: Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia publication-title: Psychopharmacology contributor: fullname: Khanzode – volume: 143 start-page: 213 year: 2012 end-page: 220 ident: bb0185 article-title: Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense(Hutch.) Milne-Redh (Astera-ceae) in rodents publication-title: J Ethnopharmacol contributor: fullname: Talla – volume: 64 start-page: 297 year: 1996 end-page: 304 ident: bb0290 article-title: n-3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supple-mentation publication-title: Am J Clin Nutr contributor: fullname: Luberto – volume: 75 start-page: 38 year: 2014 end-page: 46 ident: bb0265 article-title: Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency publication-title: Biol Psy-chiatry contributor: fullname: Tock – volume: 16 start-page: 241 year: 2012 ident: bb0110 article-title: The effects of omega 3 fatty acid supplementa-tion on brain tissue oxidative status in aged wistar rats publication-title: Hippokratia contributor: fullname: Krstic – volume: 69 start-page: 429 year: 2003 end-page: 436 ident: bb0250 article-title: Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia publication-title: Prostaglandins Leukot Essent Fatty Acids contributor: fullname: van Kammen – volume: 30 start-page: 193 year: 1998 end-page: 208 ident: bb0055 article-title: The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia publication-title: Schizophr Res contributor: fullname: Horrobin – volume: 31 start-page: 365 year: 2007 end-page: 369 ident: bb0305 article-title: Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations publication-title: Prog Neuropsychopharmacol Biol Psychiatry contributor: fullname: Chianetta – volume: 25 start-page: 409 year: 2002 end-page: 432 ident: bb0015 article-title: Schizophrenia as a disorder of neurodevelopment publication-title: Annu Rev Neurosci contributor: fullname: Levitt – volume: 82 start-page: 70 year: 1959 end-page: 77 ident: bb0175 article-title: Tissue sulfhydryl groups publication-title: Arch Biochem Biophys contributor: fullname: Ellman – volume: 66 start-page: 13 year: 2009 end-page: 20 ident: bb0255 article-title: Elevated striatal dopamine function linked to pro-dromal signs of schizophrenia publication-title: Arch Gen Psychiatry contributor: fullname: Asselin – volume: 41 start-page: 748 year: 2007 end-page: 756 ident: bb0295 article-title: Docosahexaenoic acid supplementation induces dose and time dependent oxidative changes in C6 glioma cells publication-title: Free Radic Res contributor: fullname: Benedetto – volume: 257 start-page: 1220 year: 1992 end-page: 1224 ident: bb0045 article-title: Protein oxidation and aging publication-title: Science contributor: fullname: Stadtman – volume: 141 start-page: 153 year: 2012 end-page: 161 ident: bb0105 article-title: A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia publication-title: Schizophr Res contributor: fullname: Kahn – volume: 11 start-page: 523 year: 2009 end-page: 529 ident: bb0065 article-title: Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia publication-title: Bipolar Disord contributor: fullname: Sun – volume: 35 start-page: 878 year: 2011 end-page: 893 ident: bb0035 article-title: Oxidative stress in schizophrenia: an integrated approach publication-title: Neurosci Biobehav Rev contributor: fullname: Woo – volume: 126 start-page: 572 year: 1999 end-page: 574 ident: bb0155 article-title: Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist publication-title: Br J Pharmacol contributor: fullname: Holland – volume: 67 start-page: 399 year: 2000 end-page: 410 ident: bb0165 article-title: Importance of iron location in iron-induced hydroxyl radical production by brain slices publication-title: Life Sci contributor: fullname: Beley – volume: 3 start-page: 1607 year: 1983 end-page: 1619 ident: bb0225 article-title: Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons publication-title: J Neurosci contributor: fullname: Bunney – volume: 13 start-page: 71 year: 2009 end-page: 78 ident: bb0150 article-title: YKP1447, a novel potential atypical antipsychotic agent publication-title: Korean J Physiol Pharmacol contributor: fullname: Heo – volume: 141 start-page: 162 year: 2012 end-page: 167 ident: bb0115 article-title: Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia publication-title: Schizophr Res contributor: fullname: Panizzutti – volume: 7 start-page: 3354 year: 2014 end-page: 3361 ident: bb0230 article-title: Antipsychotic-like effect of minocycline in a rat model publication-title: Int J Clin Exp Med contributor: fullname: Inanir – volume: 41 start-page: 625 year: 2004 end-page: 638 ident: bb0215 article-title: Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity publication-title: Neuron contributor: fullname: Arbuckle – volume: 148 start-page: 1474 year: 1991 end-page: 1486 ident: bb0010 article-title: Dopamine in schizophrenia: a review and reconceptualization publication-title: Am J Psychiatry contributor: fullname: Ko – volume: 16 start-page: 885 year: 2011 end-page: 886 ident: bb0260 article-title: Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study publication-title: Mol Psychiatry contributor: fullname: Turkheimer – volume: 2013 start-page: 686304 year: 2013 ident: bb0235 article-title: Antipsychotic-like effect of trimetazidine in a rodent model publication-title: ScientificWorldJournal contributor: fullname: Elikucuk – volume: 13 start-page: 195 year: 1994 end-page: 207 ident: bb0100 article-title: The membrane hypothesis of schizophrenia publication-title: Schizophr Res contributor: fullname: Vaddadi – volume: 72 start-page: 248 year: 1976 end-page: 254 ident: bb0170 article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding publication-title: Anal Biochem contributor: fullname: Bradford – volume: 72 start-page: 239 year: 2005 end-page: 242 ident: bb0095 article-title: Essential fatty acids, DHA and human brain publication-title: Indian J Pediatr contributor: fullname: Singh – volume: 479 start-page: 317 year: 2010 end-page: 320 ident: bb0060 article-title: Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics publication-title: Neurosci Lett contributor: fullname: Dobrin – volume: 97 start-page: 53 year: 2005 end-page: 57 ident: bb0160 article-title: Neuropharmacological effects of the aqueous extract of Nauclea latifolia root bark in rats and mice publication-title: J Ethnopharmacol contributor: fullname: Chindo – volume: 21 start-page: 268 year: 2010 end-page: 277 ident: bb0135 article-title: Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells publication-title: J Nutr Biochem contributor: fullname: Tami – volume: 36 start-page: 7 year: 2002 end-page: 18 ident: bb0085 article-title: A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms publication-title: J Psychiatr Res contributor: fullname: Horrobin – start-page: 2 year: 1998 end-page: 45 ident: bb0190 article-title: Overview of central nervous system receptors publication-title: The RBI hand-book of receptor clarification and signal transduction contributor: fullname: Walting – volume: 47 start-page: 291 year: 1978 end-page: 296 ident: bb0220 article-title: 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and deriva-tives publication-title: Eur J Pharmacol contributor: fullname: Prosser – volume: 45 start-page: 215 year: 2013 end-page: 222 ident: bb0125 article-title: Influence of lifelong dietary fats on the brain fatty acids and amphetamine-induced behavioral responses in adult rat publication-title: Prog Neuropsychopharmacol Biol Psychiatry contributor: fullname: Dias – volume: 146 start-page: 184 year: 2013 end-page: 189 ident: bb0090 article-title: No evidence of exogenous origin for the abnor-mal glutathione redox state in schizophrenia publication-title: Schizophr Res contributor: fullname: Summerfelt – volume: 53 start-page: 77 year: 2008 end-page: 83 ident: bb0180 article-title: Race and hospital diagnoses of schizophrenia and mood disorders publication-title: Soc Work contributor: fullname: Barnes – volume: 23 start-page: 287 year: 1994 end-page: 290 ident: bb0145 article-title: Possible evidence of angiotensin II and endogenous opioid modulation of novelty-induced rearing in the rat publication-title: Afr J Med Med Sci contributor: fullname: Ukponmwan – volume: 67 start-page: 146 year: 2010 end-page: 154 ident: bb0200 article-title: Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial publication-title: Arch Gen Psychiatry contributor: fullname: Papageorgiou – volume: 4 start-page: 208 year: 2013 ident: bb0300 article-title: Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hip-pocampus publication-title: Front Genet contributor: fullname: Föcking – volume: 6 start-page: 634 year: 2001 end-page: 646 ident: bb0030 article-title: Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms publication-title: Mol Psychiatry contributor: fullname: Pearce – volume: 32 start-page: 179 year: 2012 end-page: 185 ident: bb0080 article-title: Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies publication-title: J Clin Psychopharmacol contributor: fullname: Berger – volume: 41 start-page: 625 year: 2004 ident: 10.1097/MAJ.0000000000000531_bb0215 article-title: Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity publication-title: Neuron doi: 10.1016/S0896-6273(04)00048-0 contributor: fullname: Yao – volume: 158 start-page: 2071 year: 2001 ident: 10.1097/MAJ.0000000000000531_bb0280 article-title: A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cog-nitive impairment in schizophrenia publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.158.12.2071 contributor: fullname: Fenton – volume: 18 start-page: 119 year: 2006 ident: 10.1097/MAJ.0000000000000531_bb0130 article-title: Prevention of oxidative stress-mediated neuropa-thology and improved clinical outcome by adjunctive use of a combina-tion of antioxidants and omega-3 fatty acids in schizophrenia publication-title: Int Rev Psychiatry doi: 10.1080/09540260600581993 contributor: fullname: Mahadik – volume: 141 start-page: 153 year: 2012 ident: 10.1097/MAJ.0000000000000531_bb0105 article-title: A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia publication-title: Schizophr Res doi: 10.1016/j.schres.2012.08.014 contributor: fullname: van der Kemp – volume: 23 start-page: 287 year: 1994 ident: 10.1097/MAJ.0000000000000531_bb0145 article-title: Possible evidence of angiotensin II and endogenous opioid modulation of novelty-induced rearing in the rat publication-title: Afr J Med Med Sci contributor: fullname: Ajayi – volume: 126 start-page: 572 year: 1999 ident: 10.1097/MAJ.0000000000000531_bb0155 article-title: Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0702350 contributor: fullname: Reavill – volume: 479 start-page: 317 year: 2010 ident: 10.1097/MAJ.0000000000000531_bb0060 article-title: Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics publication-title: Neurosci Lett doi: 10.1016/j.neulet.2010.05.088 contributor: fullname: Padurariu – volume: 21 start-page: 268 year: 2010 ident: 10.1097/MAJ.0000000000000531_bb0135 article-title: Effects of eicosapentaenoic acid on synaptic plasticity, fatty acid profile and phosphoinositide 3-kinase signaling in rat hippocampus and differentiated PC12 cells publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2008.12.015 contributor: fullname: Kawashima – volume: 121 start-page: 65 year: 2015 ident: 10.1097/MAJ.0000000000000531_bb0270 article-title: Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizo-phrenia publication-title: Life Sci doi: 10.1016/j.lfs.2014.11.025 contributor: fullname: Zugno – start-page: 2 year: 1998 ident: 10.1097/MAJ.0000000000000531_bb0190 article-title: Overview of central nervous system receptors contributor: fullname: Walting – volume: 75 start-page: 38 year: 2014 ident: 10.1097/MAJ.0000000000000531_bb0265 article-title: Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency publication-title: Biol Psy-chiatry doi: 10.1016/j.biopsych.2013.06.007 contributor: fullname: Bondi – volume: 259 start-page: 223 year: 2013 ident: 10.1097/MAJ.0000000000000531_bb0120 article-title: Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia publication-title: Neuroscience doi: 10.1016/j.neuroscience.2013.11.049 contributor: fullname: Zugno – volume: 67 start-page: 146 year: 2010 ident: 10.1097/MAJ.0000000000000531_bb0200 article-title: Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2009.192 contributor: fullname: Amminger – volume: 122 start-page: 593 year: 1999 ident: 10.1097/MAJ.0000000000000531_bb0025 article-title: The neuropathology of schizophrenia. A critical review of the data and their interpretation publication-title: Brain doi: 10.1093/brain/122.4.593 contributor: fullname: Harrison – volume: 36 start-page: 7 year: 2002 ident: 10.1097/MAJ.0000000000000531_bb0085 article-title: A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms publication-title: J Psychiatr Res doi: 10.1016/S0022-3956(01)00048-6 contributor: fullname: Peet – volume: 45 start-page: 215 year: 2013 ident: 10.1097/MAJ.0000000000000531_bb0125 article-title: Influence of lifelong dietary fats on the brain fatty acids and amphetamine-induced behavioral responses in adult rat publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2013.06.007 contributor: fullname: Trevizol – volume: 47 start-page: 291 year: 1978 ident: 10.1097/MAJ.0000000000000531_bb0220 article-title: 3H-Haloperidol binding to dopamine receptors in rat corpus striatum: influence of chlorpromazine metabolites and deriva-tives publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(78)90236-4 contributor: fullname: Creese – volume: 66 start-page: 13 year: 2009 ident: 10.1097/MAJ.0000000000000531_bb0255 article-title: Elevated striatal dopamine function linked to pro-dromal signs of schizophrenia publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2008.514 contributor: fullname: Howes – volume: 13 start-page: 71 year: 2009 ident: 10.1097/MAJ.0000000000000531_bb0150 article-title: YKP1447, a novel potential atypical antipsychotic agent publication-title: Korean J Physiol Pharmacol doi: 10.4196/kjpp.2009.13.2.71 contributor: fullname: Dong – volume: 9 start-page: 301 year: 2011 ident: 10.1097/MAJ.0000000000000531_bb0040 article-title: Oxidative stress in schizophrenia publication-title: Curr Neuropharmacol doi: 10.2174/157015911795596595 contributor: fullname: Boskovic – volume: 41 start-page: 748 year: 2007 ident: 10.1097/MAJ.0000000000000531_bb0295 article-title: Docosahexaenoic acid supplementation induces dose and time dependent oxidative changes in C6 glioma cells publication-title: Free Radic Res doi: 10.1080/10715760701324067 contributor: fullname: Leonardi – volume: 35 start-page: 878 year: 2011 ident: 10.1097/MAJ.0000000000000531_bb0035 article-title: Oxidative stress in schizophrenia: an integrated approach publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2010.10.008 contributor: fullname: Bitanihirwe – volume: 68 start-page: 1867 year: 2007 ident: 10.1097/MAJ.0000000000000531_bb0075 article-title: Ethyl-eicosapentaenoic acid in first-episode psycho-sis: a randomized, placebo-controlled trial publication-title: J Clin Psychiatry doi: 10.4088/JCP.v68n1206 contributor: fullname: Berger – volume: 32 start-page: 1677 year: 2008 ident: 10.1097/MAJ.0000000000000531_bb0070 article-title: Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizo-phrenia publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2008.07.001 contributor: fullname: Kunz – volume: 148 start-page: 1474 year: 1991 ident: 10.1097/MAJ.0000000000000531_bb0010 article-title: Dopamine in schizophrenia: a review and reconceptualization publication-title: Am J Psychiatry doi: 10.1176/ajp.148.11.1474 contributor: fullname: Davis – volume: 32 start-page: 179 year: 2012 ident: 10.1097/MAJ.0000000000000531_bb0080 article-title: Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies publication-title: J Clin Psychopharmacol doi: 10.1097/JCP.0b013e318248b7bb contributor: fullname: Fusar-Poli – volume: 32 start-page: 89 year: 2005 ident: 10.1097/MAJ.0000000000000531_bb0240 article-title: Lipid signaling in neural plasticity, brain repair, and neuroprotection publication-title: Mol Neurobiol doi: 10.1385/MN:32:1:089 contributor: fullname: Bazan – volume: 146 start-page: 184 year: 2013 ident: 10.1097/MAJ.0000000000000531_bb0090 article-title: No evidence of exogenous origin for the abnor-mal glutathione redox state in schizophrenia publication-title: Schizophr Res doi: 10.1016/j.schres.2013.02.001 contributor: fullname: Ballesteros – volume: 3 start-page: 1607 year: 1983 ident: 10.1097/MAJ.0000000000000531_bb0225 article-title: Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons publication-title: J Neurosci doi: 10.1523/JNEUROSCI.03-08-01607.1983 contributor: fullname: Chiodo – volume: 58 start-page: 1 year: 2002 ident: 10.1097/MAJ.0000000000000531_bb0245 article-title: Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsy-chotics publication-title: Schizophr Res doi: 10.1016/S0920-9964(01)00334-6 contributor: fullname: Khan – volume: 25 start-page: 409 year: 2002 ident: 10.1097/MAJ.0000000000000531_bb0015 article-title: Schizophrenia as a disorder of neurodevelopment publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.25.112701.142754 contributor: fullname: Lewis – volume: 257 start-page: 1220 year: 1992 ident: 10.1097/MAJ.0000000000000531_bb0045 article-title: Protein oxidation and aging publication-title: Science doi: 10.1126/science.1355616 contributor: fullname: Stadtman – volume: 4 start-page: 208 year: 2013 ident: 10.1097/MAJ.0000000000000531_bb0300 article-title: Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hip-pocampus publication-title: Front Genet doi: 10.3389/fgene.2013.00208 contributor: fullname: English – volume: 143 start-page: 213 year: 2012 ident: 10.1097/MAJ.0000000000000531_bb0185 article-title: Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense(Hutch.) Milne-Redh (Astera-ceae) in rodents publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2012.06.026 contributor: fullname: Sotoing Taïwe – volume: 26 start-page: 995 year: 2002 ident: 10.1097/MAJ.0000000000000531_bb0050 article-title: The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients: the possible role of oxidant/antioxidant imbalance publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/S0278-5846(02)00220-8 contributor: fullname: Akyol – volume: 90 start-page: 1 year: 2014 ident: 10.1097/MAJ.0000000000000531_bb0285 article-title: Long-chain omega 3 fatty acids: molecular bases of potential antioxidant actions publication-title: Prostaglandins Leukot Essent Fatty Acids doi: 10.1016/j.plefa.2013.11.002 contributor: fullname: Giordano – volume: 64 start-page: 297 year: 1996 ident: 10.1097/MAJ.0000000000000531_bb0290 article-title: n-3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supple-mentation publication-title: Am J Clin Nutr doi: 10.1093/ajcn/64.3.297 contributor: fullname: Palozza – volume: 31 start-page: 365 year: 2007 ident: 10.1097/MAJ.0000000000000531_bb0305 article-title: Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2006.09.012 contributor: fullname: Grignon – volume: 7 start-page: 3354 year: 2014 ident: 10.1097/MAJ.0000000000000531_bb0230 article-title: Antipsychotic-like effect of minocycline in a rat model publication-title: Int J Clin Exp Med contributor: fullname: Dokuyucu – volume: 53 start-page: 77 year: 2008 ident: 10.1097/MAJ.0000000000000531_bb0180 article-title: Race and hospital diagnoses of schizophrenia and mood disorders publication-title: Soc Work doi: 10.1093/sw/53.1.77 contributor: fullname: Barnes – volume: 6 start-page: 634 year: 2001 ident: 10.1097/MAJ.0000000000000531_bb0030 article-title: Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4000956 contributor: fullname: Pearce – volume: 35 start-page: 2281 year: 1984 ident: 10.1097/MAJ.0000000000000531_bb0195 article-title: Two dopamine receptors: biochemistry, physiology and pharmacology publication-title: Life Sci doi: 10.1016/0024-3205(84)90519-8 contributor: fullname: Stoof – volume: 82 start-page: 70 year: 1959 ident: 10.1097/MAJ.0000000000000531_bb0175 article-title: Tissue sulfhydryl groups publication-title: Arch Biochem Biophys doi: 10.1016/0003-9861(59)90090-6 contributor: fullname: Ellman – volume: 207 start-page: 81 year: 2014 ident: 10.1097/MAJ.0000000000000531_bb0140 article-title: Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3 publication-title: Chem Biol Interact doi: 10.1016/j.cbi.2013.10.008 contributor: fullname: Shaaban – volume: 166 start-page: 135 year: 1997 ident: 10.1097/MAJ.0000000000000531_bb0205 article-title: The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cyto-kine production in rats fed a variety of fat diets publication-title: Mol Cell Biochem doi: 10.1023/A:1006875010120 contributor: fullname: Tappia – volume: 72 start-page: 248 year: 1976 ident: 10.1097/MAJ.0000000000000531_bb0170 article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding publication-title: Anal Biochem doi: 10.1016/0003-2697(76)90527-3 contributor: fullname: Bradford – volume: 72 start-page: 239 year: 2005 ident: 10.1097/MAJ.0000000000000531_bb0095 article-title: Essential fatty acids, DHA and human brain publication-title: Indian J Pediatr doi: 10.1007/BF02859265 contributor: fullname: Singh – volume: 67 start-page: 399 year: 2000 ident: 10.1097/MAJ.0000000000000531_bb0165 article-title: Importance of iron location in iron-induced hydroxyl radical production by brain slices publication-title: Life Sci doi: 10.1016/S0024-3205(00)00638-X contributor: fullname: Demougeot – volume: 97 start-page: 53 year: 2005 ident: 10.1097/MAJ.0000000000000531_bb0160 article-title: Neuropharmacological effects of the aqueous extract of Nauclea latifolia root bark in rats and mice publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2004.10.003 contributor: fullname: Amos – volume: 16 start-page: 241 year: 2012 ident: 10.1097/MAJ.0000000000000531_bb0110 article-title: The effects of omega 3 fatty acid supplementa-tion on brain tissue oxidative status in aged wistar rats publication-title: Hippokratia contributor: fullname: Avramovic – volume: 182 start-page: 494 year: 2005 ident: 10.1097/MAJ.0000000000000531_bb0210 article-title: Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia publication-title: Psychopharmacology doi: 10.1007/s00213-005-0117-1 contributor: fullname: Dakhale – volume: 69 start-page: 429 year: 2003 ident: 10.1097/MAJ.0000000000000531_bb0250 article-title: Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia publication-title: Prostaglandins Leukot Essent Fatty Acids doi: 10.1016/j.plefa.2003.08.015 contributor: fullname: Yao – volume: 29 start-page: 671 year: 2003 ident: 10.1097/MAJ.0000000000000531_bb0020 article-title: The stress cascade and schizophrenia: etiology and onset publication-title: Schizophr Bull doi: 10.1093/oxfordjournals.schbul.a007038 contributor: fullname: Corcoran – volume: 16 start-page: 885 year: 2011 ident: 10.1097/MAJ.0000000000000531_bb0260 article-title: Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study publication-title: Mol Psychiatry doi: 10.1038/mp.2011.20 contributor: fullname: Howes – volume: 11 start-page: 523 year: 2009 ident: 10.1097/MAJ.0000000000000531_bb0065 article-title: Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia publication-title: Bipolar Disord doi: 10.1111/j.1399-5618.2009.00717.x contributor: fullname: Wang – volume: 49 start-page: 243 year: 2001 ident: 10.1097/MAJ.0000000000000531_bb0275 article-title: Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia publication-title: Schizophr Res doi: 10.1016/S0920-9964(00)00083-9 contributor: fullname: Peet – volume: 30 start-page: 193 year: 1998 ident: 10.1097/MAJ.0000000000000531_bb0055 article-title: The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia publication-title: Schizophr Res doi: 10.1016/S0920-9964(97)00151-5 contributor: fullname: Horrobin – volume: 141 start-page: 162 year: 2012 ident: 10.1097/MAJ.0000000000000531_bb0115 article-title: Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia publication-title: Schizophr Res doi: 10.1016/j.schres.2012.08.002 contributor: fullname: Gama – volume: 2013 start-page: 686304 year: 2013 ident: 10.1097/MAJ.0000000000000531_bb0235 article-title: Antipsychotic-like effect of trimetazidine in a rodent model publication-title: ScientificWorldJournal doi: 10.1155/2013/686304 contributor: fullname: Erbas – volume: 13 start-page: 195 year: 1994 ident: 10.1097/MAJ.0000000000000531_bb0100 article-title: The membrane hypothesis of schizophrenia publication-title: Schizophr Res doi: 10.1016/0920-9964(94)90043-4 contributor: fullname: Horrobin |
SSID | ssj0012813 |
Score | 2.1837142 |
Snippet | Background In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a... In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a new... BACKGROUND:In humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a... BACKGROUNDIn humans, omega-3 fatty acids are necessary for cell membranes, brain function and nerve transmission continuation. When animals are exposed to a... |
SourceID | proquest crossref pubmed wolterskluwer elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 212 |
SubjectTerms | Animals Antipsychotic Agents - pharmacology Antipsychotic effect Apomorphine - pharmacology Behavior, Animal - drug effects Brain - drug effects Brain - metabolism Chlorpromazine - pharmacology Docosahexaenoic Acids - pharmacology Dopamine Agonists - pharmacology Eicosapentaenoic Acid - pharmacology Glutathione - metabolism Internal Medicine Lipid Peroxidation - drug effects Male Malondialdehyde - metabolism Omega-3 fatty acids Oxidative stress Oxidative Stress - drug effects Rats, Wistar Stereotyped Behavior - drug effects |
Title | The Antipsychotic Effects of Omega-3 Fatty Acids in Rats |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0002962915412698 https://dx.doi.org/10.1097/MAJ.0000000000000531 https://www.ncbi.nlm.nih.gov/pubmed/26200950 https://search.proquest.com/docview/1708898579 |
Volume | 350 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdpB2NjjH0v-8KDvQVvlmRb9mNIU7KNbNCmMPYiJEfuTBY7zDaj__1Olhw7zbovWB5MkGVL1p3ufifdnRB6hU1WE-oSGUjXX1LfjcMAhKGggS9BxZFmQX92yj58io6m_nQwaI807Mr-K6WhDGitI2f_gtrbl0IB_AeawxWoDtc_pvs4rzIbXpUlo2nnsvFxrc6FS0fHogLwPU4y4w57Ikw-pxalLrpwk7yfW0KD1LXd2bGqs9sLKlYiuWig6Fx9WatqNBN5ljbOAvOtW_Gk2BTnX2tdeLbOKi2qKrME29U5Klb1RZ3UFtWqze7ttzm815wWptaid8-uXeBg65zVl8dxaNc8rDymJhOtZTy6I11JT1ETE_S5pwNMbuH5-J3JTdn-AqttdlJuTyfvsVuS1557qvuiuwKYEpPQHI19KRU35iXhHt-reoCuEZBzWsx-Dk62m1gkwrS1vnT1NnIzZm9-1rurkNG-5XMT3fpeaGeKctXEUvQQ0eIOum1NGWdsePAuGqj8Hro-t84a91EEbOTssKJjWdEpUseyotOwotOwopPljmbFB-jseLqYzFx7UIeb-IDv3ChWej_e81KWhhIAZIJ9yWjKgiVbMpyGngiXjKTMTwShgmlMi2UcSRwqpmRCH6LDvMjVY-QEqaShFDKKU-UnJJJgVqURdA4M4ZiGeIjcdpD4xuRj4a0fBQwqvzyoQ8TakeRtrDFoR1XayVPyq4jaf9JOKYMyOTDab9p82ZKMg7DWO3AiV0UNbTHtVRgFLB6iR4aW26_QJ0OAveMNEd4hLjcB0b9s8ck_f-VTdKObmM_QYfWtVs_RQbmsXzTM_ANBGsCF |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Antipsychotic+Effects+of+Omega-3+Fatty+Acids+in+Rats&rft.jtitle=The+American+journal+of+the+medical+sciences&rft.au=Kokacya%2C+Mehmet+Hanifi%2C+MD&rft.au=Copoglu%2C+Umit+Sertan%2C+MD&rft.au=Dokuyucu%2C+Recep%2C+MD&rft.au=Inanir%2C+Sema%2C+MD&rft.date=2015-09-01&rft.issn=0002-9629&rft.volume=350&rft.issue=3&rft.spage=212&rft.epage=217&rft_id=info:doi/10.1097%2FMAJ.0000000000000531&rft.externalDBID=ECK1-s2.0-S0002962915412698&rft.externalDocID=1_s2_0_S0002962915412698 |
thumbnail_m | http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00029629%2FS0002962915X53006%2Fcov150h.gif |